Association between Comprehensive Primary Care Plus and opioid prescribing and prescription fills among Medicare beneficiaries

被引:0
|
作者
Zurovac, Jelena [1 ]
Shin, Eunhae [3 ]
Earlywine, Joel [2 ]
Ghosh, Arkadipta [2 ]
Brown, Jonathan [1 ]
机构
[1] Mathematica Inc, 1100 1st St NE,12th Floor, Washington, DC 20002 USA
[2] Mathematica Inc, POB 2393, Princeton, NJ 08543 USA
[3] Univ Georgia, Dept Hlth Policy & Management, 100 Foster Rd, Athens, GA 30622 USA
关键词
Opioids; Opioid overuse; Long-term opioid use; Primary care transformation; Comprehensive Primary Care Plus; Medicare; DRUG-MONITORING PROGRAMS; UNITED-STATES; RISK; REDUCTION;
D O I
10.1016/j.josat.2024.209621
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: To examine if Medicare beneficiaries attributed to Comprehensive Primary Care Plus (CPC+) practices had a greater decrease in the potential overuse of prescription opioids relative to beneficiaries attributed to other primary care practices. Primary care practices that participated in CPC+ received enhanced Medicare payment to support five functions: access and continuity of care, care management, comprehensiveness and coordination, patient and caregiver engagement, and planned care and population health. CPC+ practices participated within two tracks starting in 2017; Track 2 practices received larger payments to support more enhanced care delivery than Track 1 practices. Methods: Employing difference-in-differences, we used Medicare claims and Part D data to examine changes in potential opioid overuse between 2016 (baseline) and 2021 (the fifth program year). Our measure of potential opioid overuse measure relies on specifications for an existing quality measure of the same name that is defined as filling opioid prescriptions at a daily dosage of 90 morphine milligram equivalents or more among beneficiaries who use opioids for at least 90 days of supply per year. A total of 40,219 Medicare fee-for-service beneficiaries used opioids long term and were attributed to 2888 CPC+ practices; 129,178 beneficiaries used opioids long term and were attributed to 6921 comparison practices. Results: Across the combined treatment and comparison groups, potential opioid overuse decreased from 19 % in 2016 to 12 % in 2021. Relative to the comparison group, beneficiaries attributed to Track 1 CPC+ practices experienced an 0.8 percentage point greater decrease in potential opioid overuse (95 % CI = -1.4, -0.2) in the third program year compared to baseline. These findings persisted in the fourth and fifth years and were similar in magnitude to those in the third year. Track 2 results were similar to Track 1 results. The findings were likely driven by changes in CPC+ clinicians' prescribing behaviors: clinicians in CPC+ practices reduced the average dosage and the number of days' supply of prescription opioids more than clinicians in comparison practices. Conclusions: A large-scale primary care delivery transformation initiative was associated with reduced potential opioid overuse among Medicare beneficiaries.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Association of State Opioid Prescription Duration Limits With Changes in Opioid Prescribing for Medicare Beneficiaries
    Cramer, John D.
    Gunaseelan, Vidhya
    Hu, Hsou Mei
    Bicket, Mark C.
    Waljee, Jennifer F.
    Brenner, Michael J.
    JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1656 - 1657
  • [2] Opioid prescription and diabetes among Medicare beneficiaries
    Casagrande, Sarah S.
    Beccera, Adan Z.
    Rust, Keith F.
    Cowie, Catherine C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 196
  • [3] Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries
    Rao, Tanvi
    Kiptanui, Zippora
    Dowell, Paul
    Triebwasser, Corey
    Alexander, G. Caleb
    Harris, Ilene
    JAMA NETWORK OPEN, 2020, 3 (03) : E200274
  • [4] Association of formulary exclusions and restrictions for opioid alternatives with opioid prescribing among medicare beneficiaries
    Rao, Tanvi
    Kiptanui, Zippora
    Dowell, Paul
    Triebwasser, Corey
    Alexander, G. Caleb
    Harris, Ilene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 163 - 164
  • [5] Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries
    Alexander, G. Caleb
    Schiman, Cuiping
    Kaestner, Robert
    MEDICAL CARE RESEARCH AND REVIEW, 2018, 75 (02) : 153 - 174
  • [6] PRESCRIPTION OPIOID MEDICATION EXPOSURE AMONG MEDICARE BENEFICIARIES
    Guilfoyle, J.
    Akincigil, A.
    VALUE IN HEALTH, 2019, 22 : S169 - S169
  • [7] The Association Between Local Economic Conditions and Opioid Prescriptions Among Disabled Medicare Beneficiaries
    Zhou, Chao
    Yu, Ning Neil
    Losby, Jan L.
    MEDICAL CARE, 2018, 56 (01) : 62 - 68
  • [8] Opioid-limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
    Kim, Yun Ji
    Kim, Ian
    Badash, Ido
    West, Jonathan
    Hur, Kevin
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2023, : 921 - 929
  • [9] Patterns of Opioid Prescribing among Medicare Advantage Beneficiaries with Pain and Cardiopulmonary Conditions
    Feder, Shelli L.
    Canavan, Maureen E.
    Wang, Shiyi
    Kent, Erin E.
    Kapo, Jennifer
    Presley, Carolyn J.
    Ross, Joseph
    Davidoff, Amy J.
    JOURNAL OF PALLIATIVE MEDICINE, 2021, 24 (02) : 195 - 204
  • [10] Geographic Variation of Inappropriate Prescription Opioid Use Among Disabled Medicare Beneficiaries
    Lo-Ciganic, Weihsuan
    Gellad, Walid F.
    Donohue, Julie
    Zhou, Lili
    Roubal, Anne M.
    Hines, Lisa
    Lindemann, Jeremiah
    Lee, Jeannie
    Lee, Jeannie
    Malone, Daniel C.
    Bhattacharjee, Sandipan
    Kwoh, C. Kent
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 627 - 627